Cancer Drugs Fund Consultation

On 31st October 2014 Cancer52 submitted its response to the NHS England Consultation: Proposals for a sustainable Cancer Drugs Fund.

You can read a summary of our submission here.

Our key calls are for

- a wider debate, just as called for by NICE, to create a consensus on what we need to enable access to new medicines for those with rare and less common cancers

- a system that:

- includes new definitions for both 'unmet need' and 'rarity'

- gives appropriate weight in re-evaluation to the needs of patients with cancers that have extremely high mortality rates or where there are limited treatment options

- is transparent

- is clinically, not financially driven

If you would like to read the Cancer52's response to the CDF (October 2014) consultation in full, please click here.